![Mary Cardosa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Cardosa
Direktor/Vorstandsmitglied bei
PHARMANIAGA
Profil
Mary Jane Cardosa is the founder of Sentinext Therapeutics Sdn.
Bhd.
(2009) and served as Director & Chief Scientific Officer from 2010 to 2012.
Current jobs include Director at the International Association for the Study of Pain, Independent Non-Executive Director at Pharmaniaga Bhd.
(starting 2024), Member at the University of Toronto, and Principal at the World Health Organization.
Former jobs include Director at PrimeraDx, Inc., Independent Non-Executive Director at Pharmaniaga Bhd.
(2022-2023), Member at Grand Challenges Canada, and Associate Professor at the School of Pharmaceutical Sciences (1994-1995).
Education includes a graduate degree from The Trustees of Columbia University in The City of New York (1975), a doctorate from the University of Oxford (1984), and an undergraduate degree from Princeton University (1974).
Aktive Positionen von Mary Cardosa
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMANIAGA | Direktor/Vorstandsmitglied | 19.07.2024 |
World Health Organization
 World Health Organization SupranationalGovernment Provides voluntary medical services | Corporate Officer/Principal | - |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
International Association for the Study of Pain
 International Association for the Study of Pain Miscellaneous Commercial ServicesCommercial Services Pain treatment professional membership organization. | Direktor/Vorstandsmitglied | - |
Integrated Research Associates Llc
 Integrated Research Associates Llc Miscellaneous Commercial ServicesCommercial Services Integrated Research Associates LLC is an American biotechnology company specializing in the development of therapeutic drugs, vaccines, and diagnostic reagents for significant human viruses of public health concern, including dengue virus (all four serotypes and a divergent strain DKE 121), Japanese encephalitis virus, Zika virus, and enteroviruses 68 and 71. The company is located in the US. The company leverages expertise in microbiology and immunology to advance vaccine platforms, such as a patented virus-like-particle vaccine for envelope viruses, and optimize therapeutic antibodies. Integrated Research Associates offers a broad panel of mouse monoclonal antibodies targeting viral envelope, nonstructural, and pre-membrane proteins, as well as inactivated viral antigens, all validated for use in diagnostic platforms including ELISA, western blot, immunofluorescence, and plaque reduction neutralization tests. The company's products support both research and quality control, with efficient online ordering and prompt shipping. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Mary Cardosa
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMANIAGA | Direktor/Vorstandsmitglied | 12.06.2023 |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Develops vaccines and therapeutics for tropical infectious diseases | Gründer | 01.01.2018 |
School of Pharmaceutical Sciences
 School of Pharmaceutical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1995 |
Universiti Malaysia Sarawak
 Universiti Malaysia Sarawak Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░░ ░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Mary Cardosa
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
PrimeraDx, Inc.
 PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaniaga Bhd.
 Pharmaniaga Bhd. Medical DistributorsDistribution Services Operates as an investment holding company, which manufactures and markets pharmaceutical products | Distribution Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
World Health Organization
World Health Organization SupranationalGovernment Provides voluntary medical services | Government |
International Association for the Study of Pain
International Association for the Study of Pain Miscellaneous Commercial ServicesCommercial Services Pain treatment professional membership organization. | Commercial Services |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Develops vaccines and therapeutics for tropical infectious diseases | Health Technology |
Grand Challenges Canada
 Grand Challenges Canada Medical/Nursing ServicesHealth Services Provides support services for healthcare | Health Services |
School of Pharmaceutical Sciences
School of Pharmaceutical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universiti Malaysia Sarawak
Universiti Malaysia Sarawak Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Integrated Research Associates Llc
Integrated Research Associates Llc Miscellaneous Commercial ServicesCommercial Services Integrated Research Associates LLC is an American biotechnology company specializing in the development of therapeutic drugs, vaccines, and diagnostic reagents for significant human viruses of public health concern, including dengue virus (all four serotypes and a divergent strain DKE 121), Japanese encephalitis virus, Zika virus, and enteroviruses 68 and 71. The company is located in the US. The company leverages expertise in microbiology and immunology to advance vaccine platforms, such as a patented virus-like-particle vaccine for envelope viruses, and optimize therapeutic antibodies. Integrated Research Associates offers a broad panel of mouse monoclonal antibodies targeting viral envelope, nonstructural, and pre-membrane proteins, as well as inactivated viral antigens, all validated for use in diagnostic platforms including ELISA, western blot, immunofluorescence, and plaque reduction neutralization tests. The company's products support both research and quality control, with efficient online ordering and prompt shipping. | Commercial Services |
